Cargando…
LITHIUM IN THE TREATMENT OF BIPOLAR DISORDER: PHARMACOLOGY AND PHARMACOGENETICS
After decades of research, the mechanism of action of lithium in preventing recurrences of bipolar disorder remains only partially understood. Lithium research is complicated by absence of suitable animal models of bipolar disorder and by having to rely on in vitro studies of peripheral tissues. A n...
Autor principal: | Alda, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125816/ https://www.ncbi.nlm.nih.gov/pubmed/25687772 http://dx.doi.org/10.1038/mp.2015.4 |
Ejemplares similares
-
Lithium: a key to the genetics of bipolar disorder
por: Cruceanu, Cristiana, et al.
Publicado: (2009) -
Synapsin II Is Involved in the Molecular Pathway of Lithium Treatment in Bipolar Disorder
por: Cruceanu, Cristiana, et al.
Publicado: (2012) -
The utility of pharmacogenetic testing to support the treatment of bipolar disorder
por: Ielmini, Marta, et al.
Publicado: (2018) -
No association between the PREP gene and lithium responsive bipolar disorder
por: Mamdani, Firoza, et al.
Publicado: (2007) -
Towards the clinical implementation of pharmacogenetics in bipolar disorder
por: Salloum, Naji C, et al.
Publicado: (2014)